Cardiovascular diseases
Conditions
Interventions
We have developed our intervention based on four-item Morisky Medication Adherence Scale (MMAS-4), which has been shown to be predictive of adherence to cardiovascular medications and blood pressure c
b) information about discharge medications (eg, therapeutic goals
how to monitor drug treatment, especially drug-food interactions and adverse drug reactions
and how to handle inaccurate dosing systems or unusual dosage forms). Subjects considered critical to success of treatment were discussed with the patient. Additional information (e.g., dosage schedul
behavioural
F02.784.176
Sponsors
Alfredo Dias de Oliveira Filho
Universidade Federal de Alagoas
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Aiming maximum inclusiveness we recruited all patients who had a discharge diagnosis of CVD and who were on antihypertensive medication.
Exclusion criteria
Exclusion criteria: Patients were excluded if they reported already using any tool to improve their adherence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication adherence was assessed by phone call with the eight-item Morisky Medication Adherence Scale (MMAS-8). Medication adherence was assessed at 1 month post hospital discharge and re-assessed 1 year after hospital discharge. The study was closed 12 months after the last patient had been discharged. Patients who had been readmitted to the study site hospital during the 12-month follow-up period did not receive the intervention again. | — |
Secondary
| Measure | Time frame |
|---|---|
| Readmission and mortality rates 1 year after their inclusion in study, consenting participants were asked to report the number of hospitalizations related to cardiovascular diseases in the study year via phone call. Deaths were confirmed via death certificate. | — |
Countries
Brazil
Contacts
Public ContactAlfredo de Oliveira Filho
Fundação de Apoio à Pesquisa do Estado de Alagoas
Outcome results
None listed